A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache

Overview

Información sobre este estudio

This study will assess the efficacy of a neuromodulation device for the treatment of episodic migraine headache.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Diagnosed with episodic migraine at least 6 months before study
  • At least 3 consecutive months of stable migraine headaches before study
  • At least 4-14 headache days per month, of which 4-14 may be migraines
  • Must not have failed on more than 2 classes of migraine preventatives

Exclusion Criteria:

  • Previous use of the experimental device
  • Pregnant
  • Using more than 1 concurrent migraine preventive
  • History of cardiovascular disease
  • Work night shifts
  • Diagnosed with vestibular migraine
  • Menstrual migraines exclusively
  • Diagnosed with post-traumatic migraine
  • Have a history of unstable mood or anxiety disorder
  • Use a hearing aid
  • Have a cochlear implant
  • Have chronic tinnitus
  • Have temporomandibular joint disease
  • Diagnosed with traumatic brain injury
  • Diagnosed with neurological disease other than headaches
  • Diagnosed vestibular and/or balance dysfunction
  • History of abusing alcohol or other drugs
  • Are experiencing medication overuse headaches
  • Have had eye surgery in the previous 3 months
  • Have had ear surgery in the previous 6 months
  • Have active ear infections or a perforated tympanic membrane
  • Have participated in another clinical trial in the last 30 days
  • Are currently participating in another clinical trial
  • Using Botulinum toxin-based treatments for migraines or cosmetic reasons
  • Taking anti-emetics more than 2 times per week (consistently)

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus

Scottsdale/Phoenix, Ariz.

Investigador principal de Mayo Clinic

Rashmi Halker Singh, M.D.

Cerrado para la inscripción

More information

Publicaciones

Publications are currently not available
.
CLS-20343895

Mayo Clinic Footer